The use of sacubitril/valsartan in different forms of heart failure

被引:0
|
作者
Abumayyaleh, Mohammad [1 ,2 ]
Hamdani, Nazha [3 ,4 ,5 ,6 ]
El-Battrawy, Ibrahim [3 ,4 ,7 ]
Akin, Ibrahim [1 ,2 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Cardiol Angiol Haemostaseol & Med Intens Care, Heidelberg, Germany
[2] DZHK German Ctr Cardiovasc Res DZHK, Partner Site, Mannheim, Germany
[3] Ruhr Univ Bochum, Inst Physiol, Dept Cellular & Translat Physiol, Bochum, Germany
[4] Univ Maastricht, Cardiovasc Res Inst, Dept Physiol, Maastricht, Netherlands
[5] Semmelweis Univ, Ctr Pharmacol & Drug Res & Dev, Dept Pharmacol & Pharmacotherapy, HCEMM SU,Cardiovasc Comorbidities Res Grp, Budapest, Hungary
[6] Ruhr Univ Bochum, Inst Forsch & Lehre IFL, Dept Mol & Expt Cardiol, Bochum, Germany
[7] Ruhr Univ Bochum, St Josef Hosp, Dept Cardiol & Rhythmol, UK RUB, Bochum, Germany
来源
IJC HEART & VASCULATURE | 2025年 / 58卷
关键词
Sacubitril/valsartan; HFrEF; HFpEF; TTS; Inflammation; Stunning;
D O I
10.1016/j.ijcha.2025.101650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Practical guidance on the use of sacubitril/valsartan for heart failure
    Andrew J. Sauer
    Robert Cole
    Brian C. Jensen
    Jay Pal
    Nakul Sharma
    Amin Yehya
    Justin Vader
    Heart Failure Reviews, 2019, 24 : 167 - 176
  • [2] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [3] Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure
    Skersick, Preston T.
    Proco, Darrian
    Sharma-Huynh, Preetika
    Montepara, Courtney A.
    Rodgers, Jo E.
    PHARMACOTHERAPY, 2022, 42 (11): : 837 - 848
  • [4] ANMCO position paper on the use of sacubitril/valsartan therapy in patients with heart failure
    Di Tano, Giuseppe
    Di Lenarda, Andrea
    Gabrielli, Domenico
    Aspromonte, Nadia
    De Maria, Renata
    Frigerio, Maria
    Iacoviello, Massimo
    Mortara, Andrea
    Murrone, Adriano
    Nardi, Federico
    Oliva, Fabrizio
    Pontremoli, Roberto
    Scherillo, Marino
    Senni, Michele
    Urbinati, Stefano
    Gulizia, Michele Massimo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2018, 19 (10) : 568 - 590
  • [5] Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
    Vanesa Gregorietti
    Teresa Lopez Fernandez
    Diego Costa
    Elías Ortega Chahla
    Andrés J. Daniele
    Cardio-Oncology, 6
  • [6] Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
    Morrow, David A.
    Velazquez, Eric J.
    Desai, Akshay S.
    DeVore, Adam D.
    Lepage, Serge
    Park, Jeong-Gun
    Sharma, Kavita
    Solomon, Scott D.
    Starling, Randall C.
    Ward, Jonathan H.
    Williamson, Kristin M.
    Zieroth, Shelley
    Hernandez, Adrian F.
    Mentz, Robert J.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (12) : 1123 - 1132
  • [7] Efficacy and Safety of Sacubitril/valsartan in Patients with Heart Failure
    Alhabeeb, Waleed
    Al Ayoubi, Fakhr
    Hayajneh, Ahmad
    Elshaer, Fayez
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2020, 9 (04): : 11 - 18
  • [8] Efficacy of Sacubitril/Valsartan in the Setting of Acute Heart Failure: A Systematic Review
    Mohyeldin, Moiud
    Tavares, Lorena B.
    Boorenie, Mustafa
    Abureesh, Deya
    Ejaz, Saman
    Durrani, Lubna
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [9] Sacubitril-valsartan in heart failure and multimorbidity patients
    Rodil Fraile, Raquel
    Malafarina, Vincenzo
    Tiberio Lopez, Gregorio
    ESC HEART FAILURE, 2018, 5 (05): : 957 - 960
  • [10] Use and Out-of-Pocket Cost of Sacubitril-Valsartan in Patients With Heart Failure
    Shore, Supriya
    Basu, Tanima
    Kamdar, Neil
    Brady, Patrick
    Birati, Edo
    Hummel, Scott L.
    Chopra, Vineet
    Nallamothu, Brahmajee K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (17):